RankAlpha logo
Back to Rankings

LNAI

Lunai BioworksF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
LNAI vs peer average
27/100
LNAI vs. peer average (F vs. D)
Grade spread
A 1 · B 1 · C 3 · D 3 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

INO is the first available peer comparator.

Early-stage therapeutics with comparable clinical and financing risk.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerINOInovio
LNAI
Lunai Bioworks
INO
Inovio
Grade
F
D
Momentum
8
40
Value
41
41
Sentiment
0
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs INO

LNAI / INO
Grade Position
Below peers
LNAI vs. peer average (F vs. D)
27/100
Momentum
8
INO
Value
41
LNAI
Sentiment
0
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs LNAI
1
INO
INO
D
40/100
-1
2
IBIO
IBIO
A
100/100
-4
3
NTLA
NTLA
C
60/100
-2
4
XCUR
Exicure Inc Common
C
60/100
-2
5
PBM
Psyence Biomedical Ltd Common
F
20/100
Even
INO is the first peer returned for this comparison set.